Name | 4-(1h-imidazol-4-ylmethyl)-piperidine |
---|
Description | Immepip is a H3 agonist. Immepip can reduce cortical histamine release. Immepip can be used for the research of neurological diseases[1]. |
---|---|
Related Catalog | |
In Vivo | Immepip (i.p.; 5, 10 mg/kg) 显著减少皮质组胺释放,但仅微弱地促进大鼠睡眠[1]。 Animal Model: Sprague-Dawley rats[1] Dosage: 5, 10 mg/kg Administration: Intraperitoneally Result: Significantly modulated brain histamine release and slight, albeit significant, decreased in sleep onset latency. |
References |
Density | 1.084 g/cm3 |
---|---|
Boiling Point | 377.4ºC at 760 mmHg |
Molecular Formula | C9H15N3 |
Molecular Weight | 165.23500 |
Flash Point | 182.1ºC |
Exact Mass | 165.12700 |
PSA | 40.71000 |
LogP | 1.28060 |
Vapour Pressure | 6.75E-06mmHg at 25°C |
Index of Refraction | 1.544 |